Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3706828rdf:typepubmed:Citationlld:pubmed
pubmed-article:3706828lifeskim:mentionsumls-concept:C0004096lld:lifeskim
pubmed-article:3706828lifeskim:mentionsumls-concept:C0025815lld:lifeskim
pubmed-article:3706828lifeskim:mentionsumls-concept:C0020268lld:lifeskim
pubmed-article:3706828lifeskim:mentionsumls-concept:C0011777lld:lifeskim
pubmed-article:3706828lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:3706828lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:3706828lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3706828pubmed:issue5lld:pubmed
pubmed-article:3706828pubmed:dateCreated1986-6-6lld:pubmed
pubmed-article:3706828pubmed:abstractTextThe short-term airway response of 14 subjects with severe asthma to equivalent low doses of intravenous hydrocortisone, methylprednisolone, and dexamethasone was examined. Overall the subjects improved without any significant differences between the three groups in subject age, baseline percent predicted FEV1, or percent predicted FEV1 at 3, 6, 9, 24, 48, and 72 hours (P greater than .05).lld:pubmed
pubmed-article:3706828pubmed:languageenglld:pubmed
pubmed-article:3706828pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3706828pubmed:citationSubsetIMlld:pubmed
pubmed-article:3706828pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3706828pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3706828pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3706828pubmed:statusMEDLINElld:pubmed
pubmed-article:3706828pubmed:monthMaylld:pubmed
pubmed-article:3706828pubmed:issn0003-4738lld:pubmed
pubmed-article:3706828pubmed:authorpubmed-author:Klaustermeyer...lld:pubmed
pubmed-article:3706828pubmed:authorpubmed-author:KwongF KFKlld:pubmed
pubmed-article:3706828pubmed:authorpubmed-author:SueM AMAlld:pubmed
pubmed-article:3706828pubmed:issnTypePrintlld:pubmed
pubmed-article:3706828pubmed:volume56lld:pubmed
pubmed-article:3706828pubmed:ownerNLMlld:pubmed
pubmed-article:3706828pubmed:authorsCompleteYlld:pubmed
pubmed-article:3706828pubmed:pagination406-9lld:pubmed
pubmed-article:3706828pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:meshHeadingpubmed-meshheading:3706828-...lld:pubmed
pubmed-article:3706828pubmed:year1986lld:pubmed
pubmed-article:3706828pubmed:articleTitleA comparison of intravenous hydrocortisone, methylprednisolone, and dexamethasone in acute bronchial asthma.lld:pubmed
pubmed-article:3706828pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3706828pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3706828pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3706828pubmed:publicationTypeControlled Clinical Triallld:pubmed